Success of Programming Fetal Growth Phenotypes Among Obese Women

被引:15
作者
Salihu, Hamisu M. [1 ]
Mbah, Alfred K.
Alio, Amina P.
Kornosky, Jennifer L.
Bruder, Karen
Belogolovkin, Victoria
机构
[1] Univ S Florida, Ctr Res & Evaluat, Lawton & Rhea Chiles Ctr Healthy Mothers & Babies, Tampa, FL 33613 USA
关键词
GLUCOSE-TOLERANCE; MATERNAL OBESITY; EXTREME OBESITY; PRENATAL-CARE; PREGNANCY; MORTALITY; AGE; PREVALENCE; CHILDHOOD; NUTRITION;
D O I
10.1097/AOG.0b013e3181ae9a47
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
OBJECTIVE: To estimate the distribution and success of programmed fetal growth phenotypes among obese women. METHODS: This was a retrospective cohort study using the Missouri maternally linked cohort files (years 19781997). Maternal body mass index was classified as Normal (18.5-24.9) (referent group), Obese (class 1, 30.0-34.9; class 2, 35.0-39.9; and extreme or class 3, 40 or more). Fetal growth phenotypes were defined as large for gestational age (LGA), appropriate for gestational age (AGA), and small for gestational age (SGA). We used adjusted odds ratio with correction for intracluster correlation to estimate the risk of neonatal mortality for each fetal growth phenotype. RESULTS: As compared with normal weight mothers, obese gravidas tended to program LGA infants at a higher and increasing rate with ascending obesity severity. The opposite effect was observed with respect to AGA and SGA programming patterns. Neonatal mortality among LGA infants was similar for obese (6.2 in 1,000) and normal (4.9 in 1,000) weight mothers (OR 1.05, 95% confidence interval [CI] 0.75-1.48) and regardless of obesity subtype. By contrast, SGA and AGA infants programmed by obese mothers experienced greater neonatal mortality as compared with those born to normal weight mothers (AGA OR 1.45, 95% Cl 1.32-1.59; SGA OR 1.72, 95% Cl 1.49-1.98). CONCLUSION: Compared with normal weight mothers, obese women are least successful at programming SGA, less successful at programming AGA, and equally as successful at programming LGA infants. (Obstet Gynecol 2009;114:333-9)
引用
收藏
页码:333 / 339
页数:7
相关论文
共 28 条
[1]  
Alexander GR, 1996, PUBLIC HEALTH REP, V111, P408
[2]  
ALEXANDER GR, 1987, AM J PREV MED, V3, P243
[3]  
Alexander WS, 1998, CYTOKINES CELL MOL T, V4, P25
[4]  
[Anonymous], 1998, CLIN GUID ID EV TREA
[5]   GROWTH INUTERO, BLOOD-PRESSURE IN CHILDHOOD AND ADULT LIFE, AND MORTALITY FROM CARDIOVASCULAR-DISEASE [J].
BARKER, DJP ;
OSMOND, C ;
GOLDING, J ;
KUH, D ;
WADSWORTH, MEJ .
BRITISH MEDICAL JOURNAL, 1989, 298 (6673) :564-567
[6]  
BARKER DJP, 1986, LANCET, V1, P1077
[7]   The prevalence and impact of overweight and obesity in an Australian obstetric population [J].
Callaway, LK ;
Prins, JB ;
Chang, AM ;
McIntyre, HD .
MEDICAL JOURNAL OF AUSTRALIA, 2006, 184 (02) :56-59
[8]   Maternal morbid obesity and the risk of adverse pregnancy outcome [J].
Cedergren, MI .
OBSTETRICS AND GYNECOLOGY, 2004, 103 (02) :219-224
[9]  
CHU SY, 2008, MATERN CHILD HL 0710
[10]  
Clayton D., 1993, STAT MODELS EPIDEMIO